← Evidence map

ArticleBlood cancer journal2024

CD56 expression predicts response to Daratumumab-based regimens.

Allen J Robinette et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

8 papers cite it

2024
2025
2026
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 38609355